Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
179
|
399
|
0.130 |
None |
0.889 |
1 |
1
|
2007 |
2019 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
146
|
280
|
0.100 |
None |
1.000 |
2 |
1
|
2007 |
2012 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
213
|
366
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Sarcoidosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
30
|
37
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2016 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
578
|
1433
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Mixed Cellularity Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
3
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Lymphocyte Count measurement
|
phenotype |
|
Laboratory Procedure
|
130
|
199
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2016 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Small Lymphocytic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
62
|
118
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Juvenile arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
40
|
60
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Activated Partial Thromboplastin Time measurement
|
phenotype |
|
Laboratory Procedure
|
16
|
22
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
253
|
667
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Child Development Disorders, Pervasive
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
165
|
379
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Primary biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
49
|
107
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Dermatitis, Atopic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
44
|
89
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Membranous glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
22
|
23
|
0.100 |
None |
1.000 |
1 |
2
|
2011 |
2011 |
Graves Disease
|
disease |
Eye Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
33
|
57
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
62
|
118
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
21
|
35
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
22
|
38
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |